The most clinically useful ovarian cancer blood tumor markers, cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), are far from ideal for early detection of the disease due to the unacceptable level of specificity and sensitivity[2]. The gene discussed is MUC16; the disease is neoplasm.